The DOI matches its Crossref record; 61 of the 63 references it cites were found in a registry or an index.
NMIIA promotes tumor growth and metastasis by activating the Wnt/β-catenin signaling pathway and EMT in pancreatic cancer
Abstract
Non-muscle myosin IIA (NMIIA) protein plays an important role in cell cytokinesis and cell migration. The role and underlying regulatory mechanisms of NMIIA in pancreatic cancer (PC) remain elusive. We found that NMIIA is highly expressed in PC tissues and contributes to PC poor progression by using open microarray datasets from the Gene Expression Omnibus (GEO), The Cancer Genome Atlas (TCGA), and PC tissue arrays. NMIIA regulates β-catenin mediated EMT to promote the proliferation, migration, invasion, and sphere formation of PC cells in vitro and in vivo. NMIIA controls the β-catenin transcriptional activity by interacting with β-catenin. Moreover, MEK/ERK signaling is critical in MLC2 (Ser19) phosphorylation, which can mediate NMIIA activity and regulate Wnt/β-catenin signaling. These findings highlight the significance of NMIIA in tumor regression and implicate NMIIA as a promising candidate for PC treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among the key regulators of PDAC metastasis is the Wnt/β‐catenin pathway.”
From Pyrvinium Pamoate Alone and With Gemcitabine Exhibits Anti‐Pancreatic Cancer Activity in 2D and 3D Cell Culture Models (2024) · cites this paper as [42]
In the citing paper
“Upon activation, this pathway leads to the translocation of β‐catenin into the nucleus where it facilitates the transcription of genes that induce EMT, invasion and migration to distant sites [41, 42]”
From Pyrvinium Pamoate Alone and With Gemcitabine Exhibits Anti‐Pancreatic Cancer Activity in 2D and 3D Cell Culture Models (2024) · cites this paper as [42]
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,854
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature reviews. Cancer · doi:10.1038/nrc822 · Cited by 6,767
Nieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492
Ryan, D. P., Hong, T. S., & Bardeesy, N. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1404198 · Cited by 2,348
Non-muscle myosin II takes centre stage in cell adhesion and migration
Vicente‐Manzanares, M., Ma, X., Adelstein, R. S., & Horwitz, A. R. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2786 · Cited by 2,137
Three-dimensional structure of myosin subfragment-1: a molecular motor
Rayment, I., Rypniewski, W. R., Schmidt‐Bäse, K., Smith, R., Tomchick, D. R., Benning, M. M., Winkelmann, D. A., Wesenberg, G. E., & Holden, H. M. (1993) · Science · doi:10.1126/science.8316857 · Cited by 2,054
Mammalian Rho GTPases: new insights into their functions from in vivo studies
Heasman, S. J., & Ridley, A. J. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2476 · Cited by 1,871
Signaling mechanisms of the epithelial-mesenchymal transition
Gonzalez, D. M., & Medici, D. (2014) · Science Signaling · doi:10.1126/scisignal.2005189 · Cited by 1,721
The small GTP-binding proteins Rac1 and Cdc42regulate the activity of the JNK/SAPK signaling pathway
Coso, O. A., Chiariello, M., Yu, J., Teramoto, H., Crespo, P., Xu, N., Miki, T., & Gutkind, J. S. (1995) · Cell · doi:10.1016/s0092-8674(05)80018-2 · Cited by 1,629
The many faces and functions of β‐catenin
Valenta, T., Hausmann, G., & Basler, K. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.150 · Cited by 1,598
Iacobuzio-Donahue, C. A., Fu, B., Yachida, S., Luo, M., Abe, H., Henderson, C. M., Vilardell, F., Wang, Z., Keller, J. W., Banerjee, P., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.7188 · Cited by 1,081
E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer
Schmalhofer, O., Brabletz, S., & Brabletz, T. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9179-y · Cited by 771
To differentiate or not — routes towards metastasis
Brabletz, T. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3265 · Cited by 638
Transcriptional regulation of cell polarity in EMT and cancer
Moreno‐Bueno, G., Portillo, F., & Cano, A. (2008) · Oncogene · doi:10.1038/onc.2008.346 · Cited by 621
Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins.Preprint
Perona, R., Montaner, S., Saniger, L., Sánchez‐Pérez, I., Bravo, R., & Lacal, J. C. (1997) · Genes & Development · doi:10.1101/gad.11.4.463 · Cited by 620
Dysregulation of Wnt/β-Catenin Signaling in Gastrointestinal Cancers
White, B. D., Chien, A. J., & Dawson, D. W. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.12.001 · Cited by 483
Hotz, B., Arndt, M., Dullat, S., Bhargava, S., Buhr, H.-J., & Hotz, H. G. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2926 · Cited by 426
Zhou, P., Li, B., Liu, F.-R., Zhang, M., Wang, Q., Liu, Y., Yao Zong, Y. U. A. N., & Li, D. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0624-9 · Cited by 338
Self-citationIdentification and Characterization of Nonmuscle Myosin II-C, a New Member of the Myosin II Family
Golomb, E., Ma, X., Jana, S. S., Preston, Y. A., Kawamoto, S., Shoham, N. G., Goldin, E., Conti, M. A., Sellers, J. R., & Adelstein, R. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309981200 · Cited by 336
Shin, S., Dimitri, C. A., Yoon, S.-O., Dowdle, W. E., & Blenis, J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.02.020 · Cited by 299
Human nonmuscle myosin heavy chains are encoded by two genes located on different chromosomes.
Simons, M., Wang, M., McBride, O. W., Kawamoto, S., Yamakawa, K., Gdula, D. A., Adelstein, R. S., & Weir, L. (1991) · Circulation Research · doi:10.1161/01.res.69.2.530 · Cited by 272
Direct in Vivo RNAi Screen Unveils Myosin IIa as a Tumor Suppressor of Squamous Cell Carcinomas
Schramek, D., Sendoel, A., Segal, J. P., Beronja, S., Heller, E., Oristian, D., Reva, B. A., & Fuchs, E. V. (2014) · Science · doi:10.1126/science.1248627 · Cited by 269
Hepatocyte Nuclear Factor 4α Suppresses the Development of Hepatocellular Carcinoma
Ning, B., Ding, J., Yin, C., Zhong, W. H., Wu, K., Zeng, X. Y., Yang, W. K., Chen, Y.-X., Zhang, J., Zhang, X., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0824 · Cited by 241
Betapudi, V., Licate, L. S., & Egelhoff, T. T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4236 · Cited by 228
Arozarena, I., Sánchez‐Laorden, B. L., Packer, L., Hidalgo-Carcedo, C., Hayward, R., Virós, A., Sahai, E. A., & Marais, R. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.10.029 · Cited by 218
EphA2 Expression Is Associated with Aggressive Features in Ovarian Carcinoma
Thaker, P. H., Deavers, M., Celestino, J., Thornton, A., Fletcher, M. S., Landen, C. N., Kinch, M. S., Kiener, P. A., & Sood, A. K. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0589 · Cited by 211
Phosphorylation of non-muscle myosin II regulatory light chain by p21-activated kinase (γ-PAK)
Chew, T., Masaracchia, R. A., Goeckeler, Z. M., & Wysolmerski, R. B. (1998) · Journal of Muscle Research and Cell Motility · doi:10.1023/a:1005417926585 · Cited by 195
Xia, H., Ng, S. S., Jiang, S., Cheung, W. K. C., Sze, J., Bian, X., Kung, H., & Lin, M. C. M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.11.093 · Cited by 193
Non-muscle myosin II in disease: mechanisms and therapeutic opportunities
Litwa, K., Horwitz, R., & Lamers, M. L. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.022103 · Cited by 176
Rac1 mediates STAT3 activation by autocrine IL-6
Faruqi, T. R., Gomez, D., Bustelo, X. R., Bar‐Sagi, D., & Reich, N. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161281298 · Cited by 149
The cytoskeletal mechanisms of cell–cell junction formation in endothelial cells
Hoelzle, M. K., & Svitkina, T. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-08-0719 · Cited by 144
Myosin-IIA Heavy-Chain Phosphorylation Regulates the Motility of MDA-MB-231 Carcinoma Cells
Dulyaninova, N. G., House, R. P., Betapudi, V., & Bresnick, A. R. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-11-1056 · Cited by 133
Endothelial cell retraction is induced by PAK2 monophosphorylation of myosin II
Zeng, Q., Lagunoff, D., Masaracchia, R. A., Goeckeler, Z. M., Côté, G. P., & Wysolmerski, R. B. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.3.471 · Cited by 129
Excess PLAC8 promotes an unconventional ERK2-dependent EMT in colon cancer
Li, C., Ma, H., Wang, Y., Cao, Z., Graves‐Deal, R., Powell, A. E., Starchenko, A., Ayers, G. D., Washington, M. K., Kamath, V. P., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71103 · Cited by 127
Li, D., Zhou, J., Wang, L., Shin, M. E., Su, P., Lei, X., Kuang, H., Guo, W., Yang, H. B., Cheng, L., et al. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.201006094 · Cited by 127
Self-citationSmith, B., Burton, L. J., Henderson, V., Randle, D. D., Morton, D. J., Smith, B. A., Taliaferro-Smith, L. D., Nagappan, P., Yates, C. C., Zayzafoon, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104987 · Cited by 117
Liu, C.-C., Cai, D.-L., Sun, F., Wu, Z.-H., Yue, B., Zhao, S.-L., Wu, X.-S., Zhang, M., Zhu, X.-W., Peng, Z.-H., et al. (2016) · Oncogene · doi:10.1038/onc.2016.339 · Cited by 112
Self-citationStrohm, C., Barančı́k, M., hl, M.-L. V. B., Kilian, S. A. R., & Schaper, W. K. A. (2000) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200008000-00012 · Cited by 109
Looking beyond the Wnt pathway for the deep nature of β‐catenin
Fagotto, F. (2013) · EMBO Reports · doi:10.1038/embor.2013.45 · Cited by 107
Beach, J. R., Hussey, G. S., Miller, T. E., Chaudhury, A., Patel, P. R., Monslow, J., Zheng, Q., Keri, R. A., Reizes, O., Bresnick, A. R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106499108 · Cited by 106
The role of non-muscle myosin IIA in aggregation and invasion of human MCF-7 breast cancer cells
Derycke, L., Stove, C. P., Vercoutter‐Edouart, A., Wever, O. D., Dollé, L., Colpaert, N., Depypere, H., Michalski, J., & Bracke, M. (2011) · The International Journal of Developmental Biology · doi:10.1387/ijdb.113336ld · Cited by 98
Cowen, D. M., Troncoso, P., Khoo, V. S., Zagars, G. K., von Eschenbach, A. C., Meistrich, M. L., & Pollack, A. S. (2002) · PubMed · Cited by 86
Telomere protection and TRF2 expression are enhanced by the canonical Wnt signalling pathway
Diala, I., Wagner, N., Magdinier, F., Shkreli, M., Sirakov, M., Bauwens, S., Schluth‐Bolard, C., Simonet, T., Renault, V. M., Ye, J., et al. (2013) · EMBO Reports · doi:10.1038/embor.2013.16 · Cited by 81
Gjoerup, O. V., Lukas, J., Bártek, J., & Willumsen, B. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18812 · Cited by 78
Du, M., Wang, G., Ismail, T. M., Gross, S. R., Fernig, D. G., Barraclough, R., & Rudland, P. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.349787 · Cited by 73
LIM kinase 1 interacts with myosin-9 and alpha-actinin-4 and promotes colorectal cancer progression
Liao, Q., Li, R., Zhou, R., Pan, Z., Xu, L., Ding, Y., & Zhao, L. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.193 · Cited by 71
A new myosin fragment: visualization of the regulatory domain
Winkelmann, D. A., Almeda, S., Vibert, P. J., & Cohen, C. (1984) · Nature · doi:10.1038/307758a0 · Cited by 61
Epithelial–mesenchymal transition in carcinomas of the female genital tract
Stewart, C. J. R., & McCluggage, W. G. (2012) · Histopathology · doi:10.1111/his.12057 · Cited by 59
Kim, J. H., & Adelstein, R. S. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22631 · Cited by 53
Ivanov, A. I., Samarin, S., Bachar, M., Parkos, C. A., & Nusrat, A. (2009) · BMC Cell Biology · doi:10.1186/1471-2121-10-36 · Cited by 53
Côté, G. P., Robinson, E. A., Appella, E., & Korn, E. D. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90814-8 · Cited by 50
D’Apolito, M., Guarnieri, V., Boncristiano, M., Zelante, L., & Savoia, A. (2002) · Gene · doi:10.1016/s0378-1119(02)00455-9 · Cited by 42
Clinicopathological Significance of NMIIA Overexpression in Human Gastric Cancer
Liu, D., Zhang, L., Shen, Z., Tan, F., Hu, Y., Yu, J., & Li, G. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131115291 · Cited by 40
Nakashima, M., Adachi, S., Yasuda, I., Yamauchi, T., Kawaguchi, J., Hanamatsu, T., Yoshioka, T., Okano, Y., Hirose, Y., Kozawa, O., et al. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-79 · Cited by 34
Choi, O. H., Park, C.-S., Itoh, K., Adelstein, R. S., & Beaven, M. A. (1996) · Journal of Muscle Research and Cell Motility · doi:10.1007/bf00140325 · Cited by 32
Coaxum, S. D., Tiedeken, J. A., Garrett-Mayer, E. S., Myers, J. N., Rosenzweig, S. A., & Neskey, D. M. (2017) · Oncotarget · doi:10.18632/oncotarget.14967 · Cited by 31
P-cadherin counteracts myosin II-B function: implications in melanoma progression
Jacobs, K., Gele, M. V., Forsyth, R. G., Brochez, L., Vanhoecke, B. W. A., Wever, O. D., & Bracke, M. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-255 · Cited by 29
Wang, C., Fu, S., Wang, M., Yu, W., Cui, Q., Wang, H., Huang, H., Dong, W., Zhang, W., Li, P., et al. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12036 · Cited by 24
LIU, T., Ye, Y., Zhang, X., Zhu, A., YANG, Z., Fu, Y., Wei, C., Liu, Q., ZHAO, C., & Wang, G. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4742 · Cited by 20
Genomic Research Advances Pancreatic Cancer’s Early Detection and Treatment:
Brower, V. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv195 · Cited by 5
Flagged first, then by citations
2 of the 63 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Wang, S., Zheng, Y., Yang, F., Zhu, L., Zhu, X.-Q., Wang, Z.-F., Wu, X.-L., Zhou, C.-H., Yan, J.-Y., Hu, B.-Y., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00659-4 · Cited by 369
Pan, J., Fang, S., Tian, H., Zhou, C., Zhao, X., Tian, H., He, J., Shen, W., Meng, X., Jin, X., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-1133-9 · Cited by 332
Lin, X., Li, A., Li, Y., Luo, R., Zou, Y., Liu, Y.-Y., Liu, C., Xie, Y., Zuo, S., Liu, Z., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0111-4 · Cited by 192
Self-citationLi, Y., Wang, Z., Su, P., Liang, Y., Li, Z., Zhang, H., Song, X., Han, D., Wang, X., Liu, Y., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.08.026 · Cited by 183
Self-citationRole of microRNA/Epithelial-to-Mesenchymal Transition Axis in the Metastasis of Bladder Cancer
Ashrafizadeh, M., Hushmandi, K., Hashemi, M., Akbari, M. E., Kubatka, P., Raei, M., Koklesová, L., Shahinozzaman, M., Mohammadinejad, R., Najafi, M., et al. (2020) · Biomolecules · doi:10.3390/biom10081159 · Cited by 108
Metadata
- Authors
- Zhou, P., Li, Y., Li, B., Zhang, M., Liu, Y., Yao, Y., & Li, D.
- Affiliations
- Shanghai Jiao Tong University (CN)
- Second Military Medical University (CN)
- Nanjing Medical University (CN)
- Corresponding author
- Liu, Yuanhua
- Li, Dong
- Venue
- Oncogene
- Published
- 2019-04-09
- Volume
- 38
- Issue
- 27
- Pages
- 5500-5515
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2939437655
- Cited by
- 108
- References
- 63
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 13 · 2023: 14 · 2022: 34 · 2021: 19 · 2020: 16 · 2019: 4
- FWCI
- 8.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China
- Innovation Program for Ph.D. students in Shanghai Jiaotong University School of Medicine
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- non-muscle myosin IIA, pancreatic cancer, Wnt/β-catenin signaling, epithelial-mesenchymal transition, tumor growth, metastasis, MEK/ERK signaling, myosin light chain 2 phosphorylation, cell proliferation, cell migration and invasion, tumor sphere formation
- MeSH terms
- Humans, Neoplasm Invasiveness, Neoplasm Metastasis, Pancreatic Neoplasms, Myosin Heavy Chains, Cell Proliferation, beta Catenin, Epithelial-Mesenchymal Transition, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
